A U.S. appeals court on Friday revived a whistleblower lawsuit accusing the Swiss drugmaker Novartis of paying illegal ...

There was a record 18% rise in homelessness in the U.S. in the last year, driven by factors like unaffordable housing, high ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...

Blue Origin entered into a highly competitive area it has long sought to join, as the U.S. Department of Defense picked the ...

It was another record-breaking year for ransomware. When file-locking malware wasn't causing widespread disruption, like ...

A federal appeals court on Friday largely rejected Starbucks' appeal of a National Labor Relations Board finding the coffee ...

BofA has agreed to pay about $906 million for the loans —roughly 92% of the value of the portfolio. The slight discount ...

Hackers compromised an employee of the data-protection company Cyberhaven and used the worker's access to potentially steal ...

UnitedHealth and Amedisys waived the right to terminate their merger agreement until a certain date, a filing showed on ...

NEW YORK (Reuters) -After closing the books on a banner year for U.S. stocks, investors expect to ride seasonal momentum into ...

The stock market climbed to record highs in 2024, extending banner gains achieved the previous year. The tech-heavy Nasdaq ...

The Dow closed higher for the sixth consecutive session on Thursday in thin year-end trading, while higher U.S. Treasury ...